Campoy Carlos 4
4 · CytomX Therapeutics, Inc. · Filed Mar 25, 2020
Insider Transaction Report
Form 4
Campoy Carlos
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-23+350,000→ 350,000 totalExercise: $4.93Exp: 2030-03-22→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The shares subject to the Inducement Option Award will vest and become exercisable as to 25% of the total number of shares subject to the option on March 23, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.